Image Image Image Image Image Image Image Image Image Image
Access
Up

Up

As-needed treatment with ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration. (FALTA)
26/03/2013

Last modified: 15 March, 2019 - 10:57